Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

54.95
BATS BZX Real-Time Price
As of 10:21am ET
 -0.14 / -0.25%
Today’s Change
54.58
Today|||52-Week Range
77.12
-20.12%
Year-to-Date
Bristol-Myers, Nektar Tie-Up for Opdivo/NKTR-214 Combo
Sep 28 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO
Sep 23 / Zacks.com - Paid Partner Content
Bristol-Myers Squibb Slides Into Value-Stock Territory
Sep 28 / TheStreet.com - Paid Partner Content
Bristol-Myers Squibb Stock Is Down, but That Means You Should Buy
Sep 22 / TheStreet.com - Paid Partner Content
Jim Cramer's Top Takeaways: Thor Industries, e.l.f. Beauty, Bristol-Myers Squibb
Sep 28 / TheStreet.com - Paid Partner Content
52-Week Company Lows
Sep 22 / GuruFocus News - Paid Partner Content
Bristol, Nektar Research Pact Aims to Boost Efficacy of Cancer Immunotherapy
Sep 27 / TheStreet.com - Paid Partner Content
Gilead to Stop GS-5745 Development for Ulcerative Colitis
Sep 22 / Zacks.com - Paid Partner Content
Dr. Lisa Bardacks Faustian Bargain
Sep 25 / Investing Channel - Paid Partner Content
Bristol-Myers Opdivo's Regulatory Application Validated in EU
Sep 21 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close55.09
Today’s open55.13
Day’s range54.58 - 55.14
Volume138,704
Average volume (3 months)9,854,852
Market cap$92.0B
Dividend yield2.77%
Data as of 10:21am ET, 09/29/2016

Growth & Valuation

Earnings growth (last year)-22.50%
Earnings growth (this year)+30.14%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+4.29%
P/E ratio32.0
Price/Sales6.97
Price/Book6.41

Competitors

 Today’s
change
Today’s
% change
AGNAllergan-4.15-1.75%
LLYEli Lilly and Co-0.70-0.87%
NVONovo Nordisk-1.36-3.11%
AZNAstraZeneca-0.63-1.86%
Data as of 10:22am ET, 09/29/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)$0.64
Annual revenue (last year)$16.6B
Annual profit (last year)$1.6B
Net profit margin9.45%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Giovanni Caforio
Chief Financial Officer &
Executive Vice President
Charles A. Bancroft
Corporate headquarters
New York, New York

Forecasts

Search for Jobs